These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23570784)

  • 1. High syndecan-1 levels in acute myeloid leukemia are associated with bleeding, thrombocytopathy, endothelial cell damage, and leukocytosis.
    Larsen AM; Leinøe EB; Johansson PI; Birgens H; Ostrowski SR
    Leuk Res; 2013 Jul; 37(7):777-83. PubMed ID: 23570784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of platelet indices and methods for evaluating platelet function in thrombocytopenic patients.
    Vinholt PJ; Hvas AM; Nybo M
    Eur J Haematol; 2014; 92(5):367-76. PubMed ID: 24400878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of haemorrhage in the early stage of acute myeloid leukaemia by flow cytometric analysis of platelet function.
    Leinoe EB; Hoffmann MH; Kjaersgaard E; Nielsen JD; Bergmann OJ; Klausen TW; Johnsen HE
    Br J Haematol; 2005 Feb; 128(4):526-32. PubMed ID: 15686463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet function tests predict bleeding in patients with acute myeloid leukemia and thrombocytopenia.
    Just Vinholt P; Højrup Knudsen G; Sperling S; Frederiksen H; Nielsen C
    Am J Hematol; 2019 Aug; 94(8):891-901. PubMed ID: 31119762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulopathy in patients with acute pulmonary embolism: a pilot study of whole blood coagulation and markers of endothelial damage.
    Lehnert P; Johansson PI; Ostrowski SR; Møller CH; Bang LE; Olsen PS; Carlsen J
    Scand J Clin Lab Invest; 2017 Feb; 77(1):19-26. PubMed ID: 27724023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ICAM-1 and LFA-1 in hyperleukocytic acute myeloid leukaemia.
    Zhang W; Zhang X; Fan X; Li D; Qiao Z
    Clin Lab Haematol; 2006 Jun; 28(3):177-82. PubMed ID: 16706934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
    Toor AA; Choo SY; Little JA
    Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
    Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
    Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between thrombocyte dysfunction and hemorrhagic manifestations in acute leukemia].
    Lychev VG; Tarasova NI
    Ter Arkh; 1975; 47(6):27-33. PubMed ID: 1059268
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of the hMICL in acute myeloid leukemia-a highly reliable disease marker at diagnosis and during follow-up.
    Larsen HØ; Roug AS; Just T; Brown GD; Hokland P
    Cytometry B Clin Cytom; 2012 Jan; 82(1):3-8. PubMed ID: 22173921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation.
    Diehl P; Aleker M; Helbing T; Sossong V; Beyersdorf F; Olschewski M; Bode C; Moser M
    Interact Cardiovasc Thorac Surg; 2010 Aug; 11(2):133-7. PubMed ID: 20472650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemostatic function and biomarkers of endothelial damage before and after platelet transfusion in patients with acute myeloid leukaemia.
    Larsen AM; Leinøe EB; Johansson PI; Larsen R; Wantzin P; Birgens H; Ostrowski SR
    Transfus Med; 2015 Jun; 25(3):174-83. PubMed ID: 26043955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway.
    Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C
    Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics and apoptotic profile of circulating endothelial cells as prognostic factors for induction treatment failure in newly diagnosed acute myeloid leukemia patients.
    Wierzbowska A; Robak T; Krawczyńska A; Pluta A; Wrzesień-Kuś A; Cebula B; Robak E; Smolewski P
    Ann Hematol; 2008 Feb; 87(2):97-106. PubMed ID: 17849117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Rebulla P; Finazzi G; Marangoni F; Avvisati G; Gugliotta L; Tognoni G; Barbui T; Mandelli F; Sirchia G
    N Engl J Med; 1997 Dec; 337(26):1870-5. PubMed ID: 9407153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cell activation contributes to the release of procoagulant microparticles during acute cardiac allograft rejection.
    Morel O; Ohlmann P; Epailly E; Bakouboula B; Zobairi F; Jesel L; Meyer N; Chenard MP; Freyssinet JM; Bareiss P; Mazzucotelli JP; Toti F
    J Heart Lung Transplant; 2008 Jan; 27(1):38-45. PubMed ID: 18187085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low platelet counts alone do not cause bleeding in an experimental immune thrombocytopenic purpura in mice.
    Domínguez V; Govezensky T; Gevorkian G; Larralde C
    Haematologica; 2003 Jun; 88(6):679-87. PubMed ID: 12801844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia.
    Webert K; Cook RJ; Sigouin CS; Rebulla P; Heddle NM
    Haematologica; 2006 Nov; 91(11):1530-7. PubMed ID: 17043016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
    Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of massive pulmonary hemorrhage in acute leukemia.
    Smith LJ; Katzenstein AL
    Arch Intern Med; 1982 Nov; 142(12):2149-52. PubMed ID: 6958217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.